tiprankstipranks
Yakult Honsha Co Ltd (YKLTF)
OTHER OTC:YKLTF
Holding YKLTF?
Track your performance easily

Yakult Honsha Co (YKLTF) Stock Price & Analysis

2 Followers

YKLTF Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%2.38%5.98%91.64%
0.00%
Insiders
5.98% Other Institutional Investors
91.64% Public Companies and
Individual Investors

YKLTF FAQ

What was Yakult Honsha Co Ltd’s price range in the past 12 months?
Yakult Honsha Co Ltd lowest stock price was $15.11 and its highest was $32.89 in the past 12 months.
    What is Yakult Honsha Co Ltd’s market cap?
    Currently, no data Available
    When is Yakult Honsha Co Ltd’s upcoming earnings report date?
    Yakult Honsha Co Ltd’s upcoming earnings report date is Jul 30, 2024 which is 120 days ago.
      How were Yakult Honsha Co Ltd’s earnings last quarter?
      Yakult Honsha Co Ltd released its earnings results on May 14, 2024. The company reported $0.156 earnings per share for the quarter, missing the consensus estimate of $0.168 by -$0.012.
        Is Yakult Honsha Co Ltd overvalued?
        According to Wall Street analysts Yakult Honsha Co Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Yakult Honsha Co Ltd pay dividends?
          Yakult Honsha Co Ltd pays a Annually dividend of $0.2 which represents an annual dividend yield of 2.07%. See more information on Yakult Honsha Co Ltd dividends here
            What is Yakult Honsha Co Ltd’s EPS estimate?
            Yakult Honsha Co Ltd’s EPS estimate is $0.29.
              How many shares outstanding does Yakult Honsha Co Ltd have?
              Yakult Honsha Co Ltd has 342,090,850 shares outstanding.
                What happened to Yakult Honsha Co Ltd’s price movement after its last earnings report?
                Yakult Honsha Co Ltd reported an EPS of $0.156 in its last earnings report, missing expectations of $0.168. Following the earnings report the stock price went down -2.595%.
                  Which hedge fund is a major shareholder of Yakult Honsha Co Ltd?
                  Currently, no hedge funds are holding shares in YKLTF
                  ---

                  Yakult Honsha Co Stock Smart Score

                  10
                  Unlock Smart Score
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Negative
                  20 days / 200 days
                  Momentum
                  -43.53%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  9.58%
                  Trailing 12-Months
                  Asset Growth
                  -2.22%
                  Trailing 12-Months

                  Company Description

                  Yakult Honsha Co Ltd

                  Yakult Honsha Co., Ltd. engages in the manufacture and sale of food and beverage products, cosmetics, and pharmaceuticals. It operates through the following segments: Food and Beverages in Japan, the Americas, Asia and Oceania, and Europe; Pharmaceuticals, and Others. The Food and Beverages segment produces and merchandises milk drinks, noodles, juices, and soft drinks. The Pharmaceuticals segment manufactures and sells anti-cancer drugs and other pharmaceutical products. The Others segment includes cosmetics and professional baseball team management. The company was founded by Minoru Shirota in 1935 and is headquartered in Tokyo, Japan.
                  ---
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  General Mills
                  Monster Beverage
                  Kraft Heinz
                  Unilever
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis